Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

About 70 Hospital Staffers Cared for Ebola Patient

October 14, 2014 8:28 am | by MARTHA MENDOZA, AP National Writer | News | Comments

About 70 staff members at Texas Health Presbyterian Hospital were involved in the care of Thomas Eric Duncan after he was hospitalized, including a nurse now being treated for the same Ebola virus that killed the Liberian man who was visiting Dallas, according to medical records his family provided to The Associated Press.

TOPICS:

How the New HealthCare.gov Stacks Up With the Old

October 14, 2014 8:23 am | by RICARDO ALONSO-ZALDIVAR, Associated Press; CALVIN WOODWARD, Associated Press | News | Comments

HealthCare.gov, the website for health insurance under President Barack Obama's health care law, has been revamped as its second enrollment season approaches. But things are still complicated, since other major provisions of the Affordable Care Act are taking effect for the first time. A look at website and program changes just ahead.

TOPICS:

Ebola Deflating Hopes for Three Poor African Economies

October 14, 2014 8:19 am | by PAUL WISEMAN, Associated Press Writers; BOUBACAR DIALLO, Associated Press Writers | News | Comments

Just as their economies had begun to recover from the man-made horror of coups and civil war, the West African nations of Guinea, Liberia and Sierra Leone have been knocked back down by a terrifying force of nature: the Ebola virus.   

TOPICS:
Advertisement

Canadian-Made Ebola Vaccine Starts Clinical Trials in Healthy Humans

October 14, 2014 8:15 am | by Will Campbell, The Canadian Press | News | Comments

Human testing of an experimental Canadian-made Ebola vaccine began Monday, with federal officials saying the drug could be shipped to West Africa within months if it proves successful.           

TOPICS:

Ireland Plans Growth Budget After Six Years of Austerity

October 14, 2014 8:11 am | by SHAWN POGATCHNIK, Associated Press | News | Comments

Finance Minister Michael Noonan and Public Expenditure Minister Brendan Howlin are unveiling a 2015 budget Tuesday expected to contain around 1 billion euros ($1.3 billion) in income tax breaks and spending increases, ending a seven-budget run that slashed 30 billion euros from the economy.

TOPICS:

J&J Beats Wall Street Third Quarter Forecasts

October 14, 2014 8:06 am | News | Comments

Johnson & Johnson has reported third-quarter earnings of $4.75 billion. The results topped Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.42 per share.    

TOPICS:

Hep C Drug Criticized As Unsustainable For Its $90K Price Tag

October 10, 2014 4:30 pm | by Associated Press | News | Comments

On the heels of the FDA’s approval of a new formulation of hepatitis C drug treatment, AIDS Healthcare Foundation (AHF), the largest global AIDS organization and a vocal critic of runaway drug pricing and drug profiteering, blasted Gilead Sciences over the pricing of its new drug formulation.                

TOPICS:

Once-A-Day Hepatitis C Pill Wins FDA Approval

October 10, 2014 4:24 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.                                 

TOPICS:
Advertisement

WHO: Ebola Death Toll Rises To More Than 4,000

October 10, 2014 4:20 pm | by JONATHAN PAYE-LAYLEH, ROBBIE COREY-BOULET, Associated Press | News | Comments

Liberian lawmakers rejected a proposal to grant President Ellen Johnson Sirleaf the power to further restrict movement and public gatherings and to confiscate property in the fight against Ebola. One legislator said such a law would have turned Liberia into a police state.                                         

TOPICS:

The Dwindling Stock Of Antibiotics, And What To Do About It

October 10, 2014 3:30 pm | by Washington University in St. Louis | News | Comments

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. Twenty-three thousand die. These experiences leave deep impressions not just on the patients but on their family and friends.

TOPICS:

Pharmaceutical Companies Share Data For Drug Design

October 10, 2014 3:16 pm | by University of California, San Diego | News | Comments

Pharmaceutical companies will collaborate with researchers at the University of California, San Diego to provide previously unreleased proprietary data for drug discovery through a new $3.7 million effort funded by the National Institutes for Health.

TOPICS:

20 Years Of Colorectal Cancer Breakthroughs For Survival

October 10, 2014 3:14 pm | by National Comprehensive Cancer Network | News | Comments

The National Comprehensive Cancer Network (NCCN) has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines published in November 1996.                   

TOPICS:

Study Examines How Doctors Use Prescription Drug Monitoring Programs

October 10, 2014 3:08 pm | by American Pain Society | News | Comments

As prescription drug abuse and overdose have escalated nationwide, prescription drug monitoring programs (PDMPs) were implemented in every state, but little is known about the types of clinicians who make the most use of PDMPs.                     

TOPICS:

Handheld Raman System Helps In Street Drug Take Down

October 10, 2014 2:56 pm | by B&W Tek, Inc. | News | Comments

With the largest library of narcotics, pills, cutting agents and precursors in the industry, the TacticID-N is changing the face of on-scene narcotics identification for our nation’s top law enforcement personnel.                                

TOPICS:

Endo Buys Struggling Auxilium for $2.6B to Augment Urology Franchise

October 10, 2014 9:36 am | News | Comments

Endo International’s $2.6 billion purchase of Auxilium Pharmaceuticals complements Endo’s urology and male health portfolio, and the company intends to leverage its resources to optimize and drive increased adoption of three key Auxilium drugs, according to an analyst with research and consulting firm GlobalData.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading